Authors: BOISSEL JP PERRET L BOUVENOT G CASTAIGNE A GERARDCOUE MJ MAILLERE P MISMETTI P VRAY M AVOUAC B BEGAUD B CAULIN C CHARPAK Y CHAUMETRIFFAUD P COSTAGLIOLA D DEGOS F DESTORS JM DOYON F FAGNANI F GIRI I GIRRE JP GOEHRS JM KHER A MOCCATTI D MUNOZ A DECURZON AP PLETAN Y ROY P VASMANT D WAJMAN A

Citation: Jp. Boissel et al., INTERMEDIATE AND SURROGATE OUTCOMES IN CL INICAL-EVALUATION OF DRUGS, Therapie, 52(4), 1997, pp. 281-285

Authors: TRIMARCO B RADZIK D VANMIEGHEM W NEVEUX E WAJMAN A ATTALI P PONSONNAILLE J

Citation: B. Trimarco et al., EFFICACY AND SAFETY OF THE 200-300-MG SUSTAINED-RELEASE FORMULATION OF DILTIAZEM ADMINISTERED ONCE-DAILY IN PATIENTS WITH STABLE ANGINA, European Journal of Clinical Pharmacology, 47(6), 1995, pp. 493-496

Authors: OLLIVIER JP WAJMAN A STALLABOURDILLON A

Citation: Jp. Ollivier et al., ANTIHYPERTENSIVE EFFICACY OF OPTIMALLY TITRATED DOSES OF ONCE-DAILY SUSTAINED-RELEASE DILTIAZEM - A PLACEBO-CONTROLLED TRIAL, Cardiology, 86(6), 1995, pp. 481-487